Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 221.20
Bid: 221.20
Ask: 222.00
Change: -19.60 (-8.14%)
Spread: 0.80 (0.362%)
Open: 216.00
High: 223.40
Low: 210.20
Prev. Close: 240.80
CRST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Mar 2016 15:00

RNS Number : 6729Q
Crest Nicholson Holdings PLC
01 March 2016
 

Crest Nicholson Holdings plc

Director/PDMR Shareholding

 

In accordance with the requirements of D.T.R 3.1.2, Crest Nicholson Holdings plc (the "Company") was notified on 1 March 2016 of the following transaction:

 

2015 DBP Award

 

Tim Beale, a PDMR of the Company, was granted an option under the DBP on 27 February 2015 in respect of the deferred element of the 2015 annual bonus payment for the financial year ending 31 October 2014. This option first became exercisable on 27 February 2016 (the "Option").

 

On 29 February 2016 in accordance with the rules of the Plan, 548 additional shares were added to the Option to reflect the value of distributions made to shareholders during the period since the grant of the Option. The additional shares added to the Option were calculated based on the prevailing ex-dividend share price associated with the respective dividend together with the value of that dividend, in proportion to the Option.

 

On 29 February 2016, Tim Beale exercised and sold the shares awarded under the Option together with the additional shares added to that Option in respect of distributions to shareholders (as set out above). The Company allotted shares from the Company's block listing facility to satisfy the exercise of the Option. Details of the exercise and sale are set out below:

 

 

Share acquired upon exercise

 

Shares sold

Shares retained

PDMR

Number

Percentage of total issued share capital

Exercise price

Number

Sale price per Share

Percentage of total issued share capital

Tim Beale

15,604

0.006%

£1.00 in total

15,604

£5.55

0.006%

Nil

 

Following the transactions set out in this announcement, the Company confirms that at the date of this announcement, Tim Beale holds the following interests in the Ordinary Shares of 5 pence of the Company:

 

PDMR

Total shareholding following transactions (including holdings of connected persons)

Total shareholding following transactions (as a percentage of total issued share capital following allotments)

Total number of shares over which options held

Tim Beale

377,165

0.15%

225,092

 

 

 

For further information please contact:

 

Kevin Maguire

Company Secretary +44 (0) 1932 580 555

 

1 March 2016

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDXIUGBGLB
Date   Source Headline
13th Jun 20247:15 amRNSDirectorate Change
13th Jun 20247:00 amRNSHalf-year Report
6th Jun 20242:19 pmRNSHolding(s) in Company
30th May 202410:44 amRNSHolding(s) in Company
30th Apr 202410:40 amRNSHolding(s) in Company
26th Apr 20243:06 pmRNSHolding(s) in Company
25th Apr 20244:45 pmRNSHolding(s) in Company
17th Apr 202410:25 amRNSBlock listing Interim Review
11th Apr 20244:53 pmRNSHolding(s) in Company
8th Apr 20244:02 pmRNSDirectorate Change
21st Mar 202411:49 amRNSHolding(s) in Company
20th Mar 20244:42 pmRNSHolding(s) in Company
19th Mar 20241:20 pmRNSResult of AGM
19th Mar 20247:00 amRNSTrading Update
7th Mar 202410:36 amRNSDirector Declaration
21st Feb 20241:13 pmRNSHolding(s) in Company
13th Feb 202411:10 amRNSAnnual Report and Notice of AGM
6th Feb 202411:51 amRNSDirector/PDMR Shareholding
6th Feb 202411:22 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSDirectorate Change
23rd Jan 20247:00 amRNSFinal Results
15th Jan 20247:00 amRNSFY23 Trading Update
10th Jan 20244:30 pmRNSHolding(s) in Company
10th Jan 20244:30 pmRNSHolding(s) in Company
24th Nov 202311:00 amRNSDirectorate Change
16th Nov 20237:00 amRNSTrading Statement
13th Nov 202310:00 amRNSDirectorate Change
3rd Nov 202310:03 amRNSDirectorate Change
17th Oct 202310:00 amRNSBlock listing Interim Review
13th Oct 20237:00 amRNSDirectorate Change
18th Sep 20234:16 pmRNSDirector/PDMR Shareholding
4th Sep 20232:39 pmRNSDirector/PDMR Shareholding
24th Aug 20239:51 amRNSHolding(s) in Company
21st Aug 20237:00 amRNSTrading Update
1st Aug 202310:11 amRNSDirector/PDMR Shareholding
25th Jul 20239:45 amRNSHolding(s) in Company
21st Jul 20235:02 pmRNSHolding(s) in Company
11th Jul 20237:00 amRNSDirectorate Change
16th Jun 20238:56 amRNSHolding(s) in Company
8th Jun 20237:00 amRNSHalf-year Report
24th May 20231:38 pmRNSChange of Joint Corporate Broker
28th Apr 202311:45 amRNSChange of Registered Office
21st Apr 202311:35 amRNSHolding(s) in Company
17th Apr 20239:00 amRNSBlock listing Interim Review
13th Apr 20236:04 pmRNSHolding(s) in Company - Replacement
13th Apr 20239:36 amRNSHolding(s) in Company
6th Apr 20233:19 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:40 pmRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Statement
13th Mar 20231:48 pmRNSBuilding Safety Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.